IsomAb Closes £7.5m Financing to Drive New Diabetic TreatmentSteve Jarvis2024-03-01T16:00:27+00:00February 21st, 2024|BioCity Nottingham, Investment, News|
Ada Lovelace Day 2023: Empowering Women In STEMSteve Jarvis2024-02-08T11:30:02+00:00October 11th, 2023|Accelerator, BioCity Glasgow, BioCity Nottingham, Colworth Park, Edinburgh Technopole, Hexagon Tower, Investment, Kent Science Park, MediCity Nottingham, News, Wilton Centre|
Why a Sustainable Life Sciences Sector Is Fundamental to Climate MitigationAmy Cooper2023-10-26T08:53:09+01:00October 6th, 2023|Article, BioCity Nottingham, Hexagon Tower, News, Wilton Centre|
HistologiX adds Visiopharm to their Histopathology WorkflowVicky Coghlan2024-02-23T12:02:24+00:00June 5th, 2023|BioCity Nottingham|
MedTech Investment: How Pioneer Group is Supporting the Game-Changers of TomorrowAmy Cooper2023-09-04T16:13:22+01:00May 23rd, 2023|Accelerator, BioCity Nottingham, Investment, MediCity Nottingham|
Drug discovery research collaboration announced by Sygnature Discovery and Daewoong PharmaVicky Coghlan2023-04-24T14:01:17+01:00April 24th, 2023|Article, BioCity Nottingham, News|
Life Science Accelerator Programme: How Cutting-edge Companies are Growing Organically at BioCity NottinghamAmy Cooper2023-04-19T13:06:42+01:00April 17th, 2023|Accelerator, BioCity Nottingham, Investment, News|
Alveron Pharma Commences Clinical Trial of New Intracranial Haemorrhage DrugVicky Coghlan2023-04-03T13:59:35+01:00March 31st, 2023|BioCity Nottingham, News|
Myconeos Innovate UK Smart Grant SuccessVicky Coghlan2023-03-28T14:48:14+01:00March 28th, 2023|BioCity Nottingham, News|
NanoSyrinx Joins Life Sciences Incubator in NottinghamAmy Cooper2023-03-27T16:05:05+01:00March 27th, 2023|Accelerator, BioCity Nottingham, Investment, News|
